secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2024-03-11T23:59:59+00:00
Accession:  0001213900-24-021186
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Estrella Immunopharma details $1M share repurchase: open market buys via 10b5-1 plan over 12 months
--------------------------------------------------------------------------------

- Board authorized up to $1,000,000 in common stock repurchases (first announced Jan 30, 2024).
- Repurchases expected via open market trades at prevailing prices under a Rule 10b5-1 plan.
- Company will use existing cash reserves; plan may be modified or terminated based on market conditions.
- Expected to occur within the next 12 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000121390024021186/0001213900-24-021186-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000121390024021186/ea0201472-8k_estrella.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-021186

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer